In lung cancer [24, 28], gastric cancer [29], and epithelial ovarian cancer [30], ALKBH5 may act as an oncogene, whereas in colon cancer [31] and pancreatic cancer [32], ALKBH5 may inhibit tumor progression. Here, ALKBH5 is linked to neoplasm.